BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36935525)

  • 1. Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy.
    Gabbay MAL; Crispim F; Dib SA
    Diabetol Metab Syndr; 2023 Mar; 15(1):51. PubMed ID: 36935525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual β-cell function after 10 years of autoimmune type 1 diabetes: prevalence, possible determinants, and implications for metabolism.
    Cheng J; Yin M; Tang X; Yan X; Xie Y; He B; Li X; Zhou Z
    Ann Transl Med; 2021 Apr; 9(8):650. PubMed ID: 33987348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
    Barker A; Lauria A; Schloot N; Hosszufalusi N; Ludvigsson J; Mathieu C; Mauricio D; Nordwall M; Van der Schueren B; Mandrup-Poulsen T; Scherbaum WA; Weets I; Gorus FK; Wareham N; Leslie RD; Pozzilli P
    Diabetes Obes Metab; 2014 Mar; 16(3):262-7. PubMed ID: 24118704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The continuous spectrum of glycaemic variability changes with pancreatic islet function: A multicentre cross-sectional study in China.
    Zhang L; Guo K; Tian Q; Ye J; Ding Z; Zhou Q; Wu J; Fan L; Pan N; Niu X; Zhao Q; Ma Y; Jiang H; Huang G; Li X; Zhou Z; Yang L
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3579. PubMed ID: 36214297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later.
    Salardi S; Porta M; Maltoni G; Cerutti F; Rovere S; Iafusco D; Tumini S; Cauvin V; Zucchini S; Cadario F; dʾAnnunzio G; Toni S; Salvatoni A; Zedda MA; Schiaffini R;
    J Diabetes Complications; 2016; 30(1):55-60. PubMed ID: 26598223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and demographic features among patients with type 1 diabetes mellitus in Henan, China.
    Yang L; Yang G; Li X
    BMC Endocr Disord; 2021 Jun; 21(1):131. PubMed ID: 34176476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Fasting C-Peptide Predicts Type 2 Diabetes Mellitus Remission in Low-BMI Chinese Patients After Roux-en-Y Gastric Bypass.
    Zhao L; Li W; Su Z; Liu Y; Zhu L; Zhu S
    J Gastrointest Surg; 2018 Oct; 22(10):1672-1678. PubMed ID: 29845572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tapering decay of β-cell function in Chinese patients with autoimmune type 1 diabetes: A four-year prospective study.
    Li X; Cheng J; Huang G; Luo S; Zhou Z
    J Diabetes; 2019 Oct; 11(10):802-808. PubMed ID: 30767397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL.
    Landgraf W; Owens DR; Frier BM; Zhang M; Bolli GB
    Diabetes Obes Metab; 2020 Mar; 22(3):315-323. PubMed ID: 31608548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes.
    Wellens MJ; Vollenbrock CE; Dekker P; Boesten LSM; Geelhoed-Duijvestijn PH; de Vries-Velraeds MMC; Nefs G; Wolffenbuttel BHR; Aanstoot HJ; van Dijk PR
    BMJ Open Diabetes Res Care; 2021 Sep; 9(1):. PubMed ID: 34526306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
    Liu L; Li X; Xiang Y; Huang G; Lin J; Yang L; Zhao Y; Yang Z; Hou C; Li Y; Liu J; Zhu D; Leslie RD; Wang X; Zhou Z;
    Diabetes Care; 2015 Jan; 38(1):16-21. PubMed ID: 25336751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry.
    Aleppo G; Calhoun P; Foster NC; Maahs DM; Shah VN; Miller KM;
    J Diabetes Complications; 2017 Dec; 31(12):1669-1673. PubMed ID: 28989086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of HbA1c reduction and hypoglycemia in type 2 diabetes mellitus individuals switching from premixed to basal insulin: an exploratory analysis of optimization study.
    Yang W; Du J; Zhang M; Hou J; Zhang X; Cui N
    Curr Med Res Opin; 2022 Nov; 38(11):1807-1814. PubMed ID: 35943899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of residual β cell function in long-standing type 1 diabetes.
    Sherr JL; Ghazi T; Wurtz A; Rink L; Herold KC
    Diabetes Metab Res Rev; 2014 Feb; 30(2):154-62. PubMed ID: 24115337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy.
    Penaforte-Saboia JG; Montenegro RM; Couri CE; Batista LA; Montenegro APDR; Fernandes VO; Akhtar H; Negrato CA; Malmegrim KCR; Moraes DA; Dias JBE; Simões BP; Gomes MB; Oliveira MC
    Front Endocrinol (Lausanne); 2017; 8():331. PubMed ID: 29218029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic complications in type 1 diabetes mellitus. Analysis of a cohort of 291 patients with a mean evolution time of 15 years].
    Chillarón JJ; Sales MP; Sagarra E; Castells I; Benaiges D; Flores Le-Roux JA; Pedro-Botet J
    Rev Clin Esp; 2012 Sep; 212(8):375-82. PubMed ID: 22765958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.
    Panero F; Novelli G; Zucco C; Fornengo P; Perotto M; Segre O; Grassi G; Cavallo-Perin P; Bruno G
    Diabetes Care; 2009 Feb; 32(2):301-5. PubMed ID: 19017769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.